• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

    1/4/24 7:59:32 AM ET
    $ABVC
    $ADN
    $AFMD
    $AREN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ABVC alert in real time by email

    Shares of Resources Connection, Inc. (NASDAQ:RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter.

    Resources Connection posted quarterly adjusted earnings of 28 cents per share, beating market estimates of 18 cents per share. The company’s quarterly sales came in at $163.1 million versus expectations of $161.936 million.

    Resources Connection shares jumped 6.5% to $14.58 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Jeffs' Brands Ltd(NASDAQ:JFBR) gained 60.6% to $5.06 in pre-market trading after surging 25% on Wednesday. Jeffs' Brands, last month, signed non-binding letters of intent with Sky Growth Partners to invest in a DLP laser-based system for counter-drone solutions and laser-based wireless charging technology.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) rose 41% to $0.1984 in pre-market trading after falling over 11% on Wednesday. Kintara Therapeutics, last month, announced a review of strategic alternatives focused on maximizing stockholder value.
    • The Arena Group Holdings, Inc. (NYSE:AREN) shares rose 26.8% to $2.65 in pre-market trading after falling over 9% on Wednesday. Arena Group Board, last month, terminated employment of CEO Ross Levinsohn.
    • 180 Life Sciences Corp. (NASDAQ:ATNF) shares gained 24.4% to $0.2550 in pre-market trading. 180 Life Sciences, last month, engaged financial advisor to explore strategic alternatives.
    • Advent Technologies Holdings, Inc. (NASDAQ:ADN) shares climbed 10.2% to $0.2259 in pre-market trading after falling over 6% on Wednesday. Advent Technologies recently announced a $2 million registered direct offering of common stock.
    • BRF S.A. (NYSE:BRFS) shares rose 9.8% to $2.80 in pre-market trading. JP Morgan analyst Lucas Ferreira, last month, downgraded BRF from Overweight to Neutral.
    • Affimed N.V. (NASDAQ:AFMD) shares gained 9.3% to $0.6426 in pre-market trading after declining 6% on Wednesday. Affimed announced sale of wholly-owned subsidiary AbCheck for $6 million.
    • SCYNEXIS, Inc. (NASDAQ:SCYX) gained 8.7% to $2.13 in pre-market trading after falling 11% on Wednesday.
    • Brooge Energy Limited (NASDAQ:BROG) gained 8.4% to $4.01 in pre-market trading after falling 8% on Wednesday. Brooge Energy recently reached a settlement with the SEC where it agreed to pay a $5 million penalty and cease any future violations.

    Losers

    • SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) shares fell 26.3% to $0.6674 in pre-market trading after announcing a proposed public offering.
    • Hallmark Financial Services, Inc. (NASDAQ:HALL) shares fell 20.5% to $0.74 in pre-market trading after declining around 25% on Wednesday. Hallmark Financial Services, on Dec. 26, announced that it intends to voluntary delist from the Nasdaq.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares fell 15.3% to $4.62 in pre-market trading. First Wave BioPharma shares jumped 43% on Wednesday after Roth MKM maintained a Buy rating on the stock and adjusted its target from $11 to $40.
    • ABVC BioPharma, Inc. (NASDAQ:ABVC) shares fell 15.1% to $1.64 in pre-market trading. ABVC BioPharma shares jumped over 60% on Wednesday after the company and its subsidiary received a milestone payment of 46 million shares from AiBtl BioPharma under a global licensing payment.
    • E-Home Household Service Holdings Limited (NASDAQ:EJH) shares fell 14.8% to $1.26 in pre-market trading after dipping 61% on Wednesday.
    • MMTec, Inc. (NASDAQ:MTC) shares fell 13.8% to $1.56 in pre-market trading after surging over 86% on Wednesday.
    • Evotec SE (NASDAQ:EVO) shares fell 11.4% to $9.37 in pre-market trading. Evotec and Owkin announced an A.I.-powered integrated multi-target collaboration in oncology, immunology and inflammation.
    • RiskOn International, Inc. (NASDAQ:ROI) shares fell 10.4% to $0.2631 in pre-market trading after dipping around 35% on Wednesday.
    • NexImmune, Inc. (NASDAQ:NEXI) fell 8.9% to $5.65 in pre-market trading after jumping around 153% on Wednesday.
    • Cal-Maine Foods, Inc. (NASDAQ:CALM) fell 5.3% to $51.94 in pre-market trading after the company reported downbeat results for its second quarter.

     

    Now Read This: Walgreens, Conagra Brands And 3 Stocks To Watch Heading Into Thursday

    Get the next $ABVC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABVC
    $ADN
    $AFMD
    $AREN

    CompanyDatePrice TargetRatingAnalyst
    Evotec SE
    $EVO
    2/3/2026Buy
    Berenberg
    Cal-Maine Foods Inc.
    $CALM
    12/1/2025$100.00Buy
    The Benchmark Company
    Resources Connection Inc.
    $RGP
    9/24/2025$7.00Buy
    Northcoast
    Cal-Maine Foods Inc.
    $CALM
    8/14/2025$110.00Neutral
    Goldman
    The Arena Group Holdings Inc.
    $AREN
    7/21/2025$10.00Buy
    Lake Street
    BRF S.A.
    $BRFS
    5/19/2025$3.50Overweight → Equal Weight
    Barclays
    Affimed N.V.
    $AFMD
    5/14/2025Buy → Neutral
    H.C. Wainwright
    Affimed N.V.
    $AFMD
    5/13/2025Outperform → Market Perform
    Leerink Partners
    More analyst ratings

    $ABVC
    $ADN
    $AFMD
    $AREN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BREXAFEMME issued to SCYNEXIS, INC

    Submission status for SCYNEXIS, INC's drug BREXAFEMME (ORIG-1) with active ingredient IBREXAFUNGERP has changed to 'Approval' on 06/01/2021. Application Category: NDA, Application Number: 214900, Application Classification: Type 1 - New Molecular Entity

    6/2/21 11:20:46 AM ET
    $SCYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BREXAFEMME issued to SCYNEXIS, INC

    Submission status for SCYNEXIS, INC's drug BREXAFEMME (SUPPL-1) with active ingredient IBREXAFUNGERP has changed to 'Approval' on 06/01/2021. Application Category: NDA, Application Number: 214900, Application Classification: Type 1 - New Molecular Entity

    6/2/21 9:57:42 AM ET
    $SCYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ADN
    $AFMD
    $AREN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Berenberg initiated coverage on Evotec SE

    Berenberg initiated coverage of Evotec SE with a rating of Buy

    2/3/26 6:55:14 AM ET
    $EVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Benchmark Company initiated coverage on Cal-Maine Foods with a new price target

    The Benchmark Company initiated coverage of Cal-Maine Foods with a rating of Buy and set a new price target of $100.00

    12/1/25 8:27:17 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    Northcoast initiated coverage on Resources Connection with a new price target

    Northcoast initiated coverage of Resources Connection with a rating of Buy and set a new price target of $7.00

    9/24/25 7:57:49 AM ET
    $RGP
    Real Estate

    $ABVC
    $ADN
    $AFMD
    $AREN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Jeffs' Brands: KeepZone AI Enters into Distribution Agreement with Assac Networks to Distribute Cybersecurity Software

    Tel Aviv, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd ("Jeffs' Brands" or the "Company") (NASDAQ:JFBR, JFBRW)), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence ("AI") – driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. ("KeepZone "), has entered into a distribution agreement (the "Agreement") with Assac Networks Ltd. ("Assac"), a leading Israeli provider of secure communication and cybersecurity solutions. Under the terms of the Agreement, KeepZone was appointed as a distributor for Assac's products in Hungary and Greece. Ass

    2/19/26 7:32:00 AM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism, announces the appointment of Eric Francois to the Company's Board of Directors. "Eric's decades of financial, transactional and operational experience will make an immediate impact to CERo's board of directors," said Chris Ehrlich, Company Chairman and Chief Executive Officer. "Furthermore, his expertise in capital raising, M&A, and business development will be an impactful addition at this stage of our development." Mr. Francois is an executive with over 25

    2/17/26 8:00:00 AM ET
    $CERO
    $CRVO
    $SCYX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Cal-Maine Foods Announces the Passing of Board Member Jim Poole, Honoring His Life and Service

    RIDGELAND, Miss., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ:CALM), the largest egg company in the United States and a leading player in the egg-based food industry, today announced with deep sadness the passing of Jim Poole, a valued member of its Board of Directors. Mr. Poole served on the Cal-Maine Foods Board since 2004, providing thoughtful leadership, steady guidance, and an unwavering commitment to the long-term success of the Company. The Board consistently valued his extensive audit and financial experience, deep risk management expertise, successful track record in business development, and broad knowledge of the general business climate in which the Company

    2/12/26 4:30:00 PM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    $ABVC
    $ADN
    $AFMD
    $AREN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kalin Katherine Bach bought $100,806 worth of shares (63,400 units at $1.59), increasing direct ownership by 155% to 104,400 units (SEC Form 4)

    4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)

    11/21/25 8:45:10 AM ET
    $SLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Cg Core Value Fund, L.P. bought $452,100 worth of shares (100,000 units at $4.52) (SEC Form 4)

    4 - RESOURCES CONNECTION, INC. (0001084765) (Issuer)

    11/13/25 4:28:22 PM ET
    $RGP
    Real Estate

    Director Fox Jeffrey H bought $452,100 worth of shares (100,000 units at $4.52) (SEC Form 4)

    4 - RESOURCES CONNECTION, INC. (0001084765) (Issuer)

    11/13/25 4:04:29 PM ET
    $RGP
    Real Estate

    $ABVC
    $ADN
    $AFMD
    $AREN
    SEC Filings

    View All

    SEC Form F-3 filed by Jeffs' Brands Ltd

    F-3 - Jeffs' Brands Ltd (0001885408) (Filer)

    2/19/26 5:26:31 PM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 6-K filed by Jeffs' Brands Ltd

    6-K - Jeffs' Brands Ltd (0001885408) (Filer)

    2/19/26 9:25:18 AM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Evotec SE

    SCHEDULE 13G/A - Evotec SE (0001412558) (Subject)

    2/17/26 6:54:02 PM ET
    $EVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ADN
    $AFMD
    $AREN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Carlile Roger D gifted 4,137 shares and received a gift of 4,137 shares, decreasing direct ownership by 0.58% to 708,025 units (SEC Form 4)

    4 - RESOURCES CONNECTION, INC. (0001084765) (Issuer)

    2/3/26 4:19:32 PM ET
    $RGP
    Real Estate

    Chief Financial Officer Macleod Ivor was granted 129,833 shares, increasing direct ownership by 48% to 398,529 units (SEC Form 4)

    4 - SCYNEXIS INC (0001178253) (Issuer)

    2/2/26 4:03:14 PM ET
    $SCYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Legal Officer Sukenick Scott was granted 129,833 shares, increasing direct ownership by 29% to 574,539 units (SEC Form 4)

    4 - SCYNEXIS INC (0001178253) (Issuer)

    2/2/26 4:02:11 PM ET
    $SCYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $ADN
    $AFMD
    $AREN
    Leadership Updates

    Live Leadership Updates

    View All

    CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism, announces the appointment of Eric Francois to the Company's Board of Directors. "Eric's decades of financial, transactional and operational experience will make an immediate impact to CERo's board of directors," said Chris Ehrlich, Company Chairman and Chief Executive Officer. "Furthermore, his expertise in capital raising, M&A, and business development will be an impactful addition at this stage of our development." Mr. Francois is an executive with over 25

    2/17/26 8:00:00 AM ET
    $CERO
    $CRVO
    $SCYX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Jeffs' Brands Appoints Security Executive Alon Dayan as CEO of KeepZone AI Inc., Strengthening Leadership in Global Homeland Security Expansion

    Tel Aviv, Israel, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd ("Jeffs' Brands" or the "Company") (NASDAQ:JFBR, JFBRW)), a data-driven e-commerce company operating on the Amazon Marketplace, today announced the appointment of Alon Dayan as Chief Executive Officer ("CEO") of its wholly-owned subsidiary, KeepZone AI Inc., formerly known as Jeffs' Brands Holdings Inc. ("KeepZone"). This strategic appointment comes on the heels of KeepZone's recent entry into the global homeland security market through a definitive distribution agreement with Scanary Ltd. ("Scanary"), positioning the Company to capitalize on the surging demand for advanced AI-driven threat detection technologies. Alon

    12/8/25 9:10:00 AM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points

    Issued on behalf of GT Biopharma, Inc. USA News Group News Commentary VANCOUVER, BC, Dec. 4, 2025 /PRNewswire/ -- Triple-therapy immunotherapy approaches are demonstrating complete leukemia elimination in preclinical models by reprogramming how cancer cells die to trigger powerful immune responses[1], while breakthrough natural killer cell research is revealing new pathways to supercharge the body's innate tumor-fighting capabilities[2]. These developments position GT Biopharma, Inc. (NASDAQ:GTBP), Geron Corporation (NASDAQ:GERN), Kura Oncology, Inc. (NASDAQ:KURA), SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), and TScan Therapeutics, Inc. (NASDAQ:TCRX). The FDA's November approval of the f

    12/4/25 12:20:00 PM ET
    $GERN
    $GTBP
    $KURA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $ABVC
    $ADN
    $AFMD
    $AREN
    Financials

    Live finance-specific insights

    View All

    TravelHost Releases Guide to the Top Romantic Getaways in Each U.S. State, Perfect for a Long-Weekend Valentine's Trip

    TravelHost, the premier travel destination publication, released its comprehensive guide to 50 of their top destinations for a long, romantic weekend getaway. From coast to coast, TravelHost has the perfect destinations for couples to find their next adventure, no matter where they live. With Valentine's Day on the horizon, this guide offers couples plenty of inspiration for memorable getaways; from Southern charm and historic streets to snow‑covered mountains and desert sunsets, the guide highlights standout destinations in every region of the country. "When it comes to choosing a place to celebrate love, every state has something worth highlighting," said Lauren Gordon, TravelHost edi

    2/2/26 1:31:00 PM ET
    $AREN
    EDP Services
    Technology

    Resources Connection, Inc. Announces Quarterly Dividend and Dividend Payment Date

    Resources Connection, Inc. (Nasdaq: RGP) (the "Company") announced today that the Board of Directors has approved a cash dividend of $0.07 per share, payable on March 20, 2026 to all stockholders of record on February 20, 2026. ABOUT RGP RGP (NASDAQ:RGP) is an award-winning global professional services firm with three decades of experience helping the world's top organizations navigate change and seize opportunity. With three integrated offerings—On-Demand Talent, Consulting, and Outsourced Services—we provide CFOs and other C-suite leaders with the flexibility to solve today's most pressing challenges on their terms, uniting strategy, execution, and talent across accounting and finance

    1/28/26 4:05:00 PM ET
    $RGP
    Real Estate

    The Arena Group Announces Debt Maturity Extensions, Supporting Refinancing Efforts

    The Arena Group Holdings, Inc. (NYSE:AREN) ("The Arena Group" or "the Company"), the brand, data and IP company home to iconic brands such as TheStreet, Parade, Men's Journal, Athlon Sports, ShopHQ and more, today announced that it has entered into agreements with its lenders to extend the maturity dates of two existing debt facilities, providing additional flexibility as the Company continues to advance its refinancing plans. Specifically, the Company has extended the maturity of its Term Loan with Renew Group Private Limited from Dec. 31, 2026 to Dec. 31, 2027, and the Company made a principal payment to retire $13 million of debt reducing outstanding principal to $97.7 million as of De

    1/7/26 5:46:00 PM ET
    $AREN
    EDP Services
    Technology

    $ABVC
    $ADN
    $AFMD
    $AREN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by ABVC BioPharma Inc.

    SC 13G/A - ABVC BIOPHARMA, INC. (0001173313) (Subject)

    11/14/24 7:33:18 PM ET
    $ABVC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by SCYNEXIS Inc.

    SC 13G/A - SCYNEXIS INC (0001178253) (Subject)

    11/14/24 7:07:26 PM ET
    $SCYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by 180 Life Sciences Corp.

    SC 13G/A - 180 Life Sciences Corp. (0001690080) (Subject)

    11/14/24 3:53:30 PM ET
    $ATNF
    Biotechnology: Pharmaceutical Preparations
    Health Care